HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$1.99
Day range
$1.85 - $2.02
Year range
$0.89 - $3.19
Market cap
58.23M USD
Avg Volume
268.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.15M | 12.70% |
Net income | -4.53M | -12.85% |
Net profit margin | — | — |
Earnings per share | -0.16 | 27.27% |
EBITDA | -4.36M | 0.16% |
Effective tax rate | -2.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.07M | -28.36% |
Total assets | 11.62M | -20.26% |
Total liabilities | 5.84M | -1.53% |
Total equity | 5.78M | — |
Shares outstanding | 29.56M | — |
Price to book | 9.95 | — |
Return on assets | -92.09% | — |
Return on capital | -152.10% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.53M | -12.85% |
Cash from operations | -3.82M | -6.55% |
Cash from investing | — | — |
Cash from financing | 2.40M | 1,744.05% |
Net change in cash | -1.31M | -13.73% |
Free cash flow | -2.03M | 23.53% |
About
Founded
2017
Website
Employees
24
